Match Day 2024 Was a ‘Good News’ Day for Neurology : Neurology Today
An abstract is unavailable.
An abstract is unavailable.
An abstract is unavailable.
Join us for this and future episodes to learn from experts as they discuss recent Neurology journal articles and hot topics in the field of…
Background and ObjectivesThe prevalence of Alzheimer dementia in the US Latino population in 2060 is projected to increase 7-fold, the highest among any other major…
Background and ObjectivesThe results of the ULTRA trial showed that ultra-early and short-term treatment with tranexamic acid (TXA) does not improve clinical outcome after aneurysmal…
An abstract is unavailable.
s In this multicentric medical records review study, adult patients with active AxSpA treated with either tofacitinib 5 mg twice daily or adalimumab 40 mg…
Background and ObjectivesNeurodevelopmental effects of fetal antiseizure medication (ASM) exposure on creativity and executive functions are poorly understood. We previously found fetal valproate exposure to…
The Food and Drug Administration (FDA) has cleared the Investigational New Drug (IND) application for SPG302 (Spinogenix, San Diego, CA) for evaluatio
Molecular Psychiatry – Antidepressant-induced membrane trafficking regulates blood-brain barrier permeability